|
121 |
Correction: Dupilumab Versus Mepolizumab for COPD: Evaluating Efficacy Outcomes Using Placebo-Adjusted Indirect Treatment Comparison
Enthalten in Pulmonary therapy 18.11.2025: 1
|
|
|
|
122 |
Double-Blind Randomized Placebo-Controlled Trial of a Lactobacillus Probiotic Blend in Chronic Obstructive Pulmonary Disease
Enthalten in Pulmonary therapy 18.11.2025: 1-13
|
|
|
|
123 |
Effect of Herbal Products and Their Active Constituents on Angiogenesis in Diabetic Wounds
Enthalten in Planta medica 17.11.2025
|
|
|
|
124 |
Bibliometric Analysis of Platelet-Rich Plasma Treatment for Hair Restoration, Facial Rejuvenation, Dental Procedures, and Gynecological Rejuvenation
Enthalten in Skin appendage disorders Bd. 11, 2025, Nr. 2: 166-175. 10 S.
|
|
|
|
125 |
Oral Supplementation with <sc>l</sc>-Cystine, Serenoa repens, Cucurbita pepo, and Pygeum africanum in Chronic Telogen Effluvium and Androgenetic Alopecia: A Double-Blind, Placebo-Controlled, Randomized Clinical Study
Enthalten in Skin appendage disorders Bd. 11, 2025, Nr. 1: 27-35. 9 S.
|
|
|
|
126 |
Unspezifische Effekte in der Physiotherapie
Enthalten in VPT-Magazin Bd. 11, 2025, Nr. 01: 20-23
|
|
|
|
127 |
Association between blood nicotinamide adenine dinucleotide levels and blood laboratory parameters at baseline and after nicotinamide mononucleotide supplementation in middle-aged healthy individuals: post hoc analysis of a randomized, double-blinded, placebo-controlled clinical trial
Enthalten in GeroScience 29.10.2025: 1-9
|
|
|
|
128 |
The effect of Edaravone on acute ischemic stroke, large vessel occlusion, not treated with intravenous thrombolytic, and endovascular thrombectomy: a double-blind placebo-controlled trial
Enthalten in Naunyn-Schmiedeberg's archives of pharmacology 24.10.2025: 1-8
|
|
|
|
129 |
Anticoagulants: Evidence-Based Medicine, Not Always Ethical
Enthalten in Seminars in thrombosis and hemostasis 23.10.2025
|
|
|
|
130 |
Efficacy and Safety of Solriamfetol on Excessive Daytime Sleepiness Associated with Obstructive Sleep Apnea in China: A Phase 3, Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial
Enthalten in CNS drugs 23.10.2025: 1-16
|
|
Administration
